Investigators designed PEGylated nano-liposomes for co-delivery Docetaxel and Resveratrol to evaluate antitumor efficiency of the combined drugs in prostate cancer.
[European Journal of Pharmaceutical Sciences]
Co-Delivery of Docetaxel and Resveratrol by Liposomes Synergistically Boosts Antitumor Efficiency against Prostate Cancer
